Vanessa Wolfeler

VANESSA WOLFELER is the head of US respiratory and GI franchise for Sanofi Genzyme. In this role, she is focused on driving and leading the team in charge of the US launches of Dupixent in asthma, nasal polyps and future indications. Previously, Wolfeler was head of global rare blood disorders. With 20 years of experience in life science industry, Wolfeler brings deep expertise in marketing and operations, strategy, business development, and people management. She is passionate about serving patients and the broader healthcare community, while being a purpose-driven people leader. @sanofius